<p>加利福尼亚州诺瓦托 --（商业资讯）--QT Imaging Holdings, Inc.（OTCQB: QTIH）（“QT Imaging” 或 “公司”）是一家致力于通过创新的无辐射成像技术转变乳腺健康管理的医疗设备公司，今天宣布已获得批准，将其普通股从 OTCQB 风险市场提升至纳斯达克资本市场。预计该公司的股票将于 2026 年 1 月 28 日星期三在纳斯达克证券市场（“纳斯达克”）以 “QTI” 作为股票代码开始交易。</p>
<p>QT Imaging 首席执行官 Raluca Dinu 博士表示：“我们非常高兴获得重新在纳斯达克资本市场上市的批准。这一里程碑代表了我们不懈努力扭转公司局面、重建商业模式、资产负债表和股本结构，重建信任，并重新聚焦于真正重要的事情。我们的团队在不确定性中以纪律、韧性和信念坚持下去，得到了始终支持我们的股东的支持。我们在被摘牌不到一年后重新回到了纳斯达克。</p>
<p>QT Imaging 的存在是出于一个简单而深刻的个人原因。女性应当拥有更好的乳腺成像选择、更早的答案，以及将她们的安全和尊严放在首位的护理。我们所做的一切都是为了将这项技术从实验室带到临床医生和她们所服务的女性手中。作为一家使命明确的更强大公司，我们相信纳斯达克上市将提高我们的知名度，扩大我们的股东基础，并支持长期价值创造。我们为自己走过的路感到自豪，并对未来充满活力。</p>
<p>QT Imaging 满足了所有纳斯达克资本市场的上市要求，包括财务、公司治理和监管标准。此次提升与公司的长期战略愿景相一致，即扩大其全球足迹并推动公司迈向技术进步的未来。</p>
<p>QT Imaging 仍然致力于通过创新、卓越运营和有序增长为股东提供持续价值。投资者可以期待在公司开启这一激动人心的新篇章时获得进一步的更新。</p>
<p><strong>关于 QT Imaging Holdings, Inc.</strong></p>
<p>QT Imaging Holdings, Inc.是一家公开的医疗设备公司，专注于使用低频声波进行创新体成像系统的研究、开发和商业化。QT Imaging Holdings, Inc.努力改善全球健康结果。其战略基于医疗成像对疾病的检测、诊断和治疗至关重要，并且应该是安全、可负担、可获得，并以患者体验为中心。有关 QT Imaging Holdings, Inc.的更多信息，请访问公司网站 www.qtimaging.com。</p>
<p>Breast Acoustic CT™是 QT Imaging Holdings, Inc.的一个关联公司的商标。</p>
<p><strong>前瞻性声明</strong></p>
<p>本新闻稿包含根据 1933 年证券法第 27A 条及 1934 年证券交易法第 21E 条的修订版的前瞻性声明。这些声明包含 “将” 和 “预计” 等词语，或其否定形式或类似术语，包括（但不限于）关于提升至纳斯达克资本市场的声明、QT Imaging 的计划、新产品开发和推出、产品销售增长和预计收入的声明。前瞻性声明涉及某些风险和不确定性，实际结果可能与任何此类声明中讨论的结果有重大差异。这些风险包括但不限于：公司提升至纳斯达克资本市场的能力，包括满足初始和持续上市要求；使用 QTI Breast Acoustic CT 扫描仪的研究结果、临床研究、QT Imaging 销售和部署 QTI Breast Acoustic CT 扫描仪的能力、将产品扩展到新领域或产品的能力、商业化技术的能力、阻碍产品全面文档和 “推向市场” 计划的意外事件、行业趋势和波动、客户需求和采购量的变化、供应商的不可预测性、吸引和留住合格人员的能力以及将产品销售提升至生产水平的能力。可能导致实际结果有所不同的其他因素在 QT Imaging Holdings 向 SEC 提交的文件以及其不时提交或提供的其他当前和定期报告的 “风险因素” 标题下和其他部分中进行了讨论。本新闻稿中的所有前瞻性声明均基于 QT Imaging Holdings 截至本日期的信息，QT Imaging Holdings 不承担更新任何前瞻性声明的义务。</p>
<p><img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjAxMjc1NDk4ODZyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjAxMjc1NDk4ODZyMQ"/></p>
<p>查看商业资讯上的源版本：https://www.businesswire.com/news/home/20260127549886/en/</p>
<p><strong>媒体咨询，请联系：</strong></p>
<p><strong>Stephen Kilmer</strong></p>
<p>投资者关系负责人</p>
<p>Stephen.Kilmer@qtimaging.com</p>
<p>电话： (646) 274-3580</p>
<p>来源：QT Imaging Holdings, Inc.</p>

<p>QT Imaging Holdings, Inc. 宣布将从 OTCQB 风险市场升级至纳斯达克资本市场，预计将于 2026 年 1 月 28 日以 "QTI" 的股票代码开始交易。首席执行官 Dr. Raluca Dinu 表示对公司扭转局势的努力感到自豪，并承诺通过创新的成像技术改善乳腺健康管理。此次升级与 QT Imaging 的战略愿景相一致，旨在实现增长和提高知名度，增强股东价值并扩大其全球影响力</p>

<p>NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (OTCQB: QTIH) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that it has received approval to uplist its common stock from the OTCQB Venture Market to the Nasdaq Capital Market. The Company’s shares are expected to commence trading on Nasdaq Stock Market LLC (“Nasdaq”) under the ticker symbol “QTI” tomorrow Wednesday, January 28, 2026.</p>
<div class="lb-trans"><p>加利福尼亚州诺瓦托 --（商业资讯）--QT Imaging Holdings, Inc.（OTCQB: QTIH）（“QT Imaging” 或 “公司”）是一家致力于通过创新的无辐射成像技术转变乳腺健康管理的医疗设备公司，今天宣布已获得批准，将其普通股从 OTCQB 风险市场提升至纳斯达克资本市场。预计该公司的股票将于 2026 年 1 月 28 日星期三在纳斯达克证券市场（“纳斯达克”）以 “QTI” 作为股票代码开始交易。</p>
</div><p>“We are very pleased to have received approval to reestablish our listing on the Nasdaq Capital Market,” said QT Imaging Chief Executive Officer Dr. Raluca Dinu. “This milestone represents relentless work to turn the company around, rebuild its business model, its balance sheet, cap table, rebuild the trust, and refocus on what truly matters. Our team pushed through uncertainty with discipline, resilience, and belief, supported every step of the way by stockholders who stayed with us. We returned to Nasdaq after less than one year of being delisted.</p>
<div class="lb-trans"><p>QT Imaging 首席执行官 Raluca Dinu 博士表示：“我们非常高兴获得重新在纳斯达克资本市场上市的批准。这一里程碑代表了我们不懈努力扭转公司局面、重建商业模式、资产负债表和股本结构，重建信任，并重新聚焦于真正重要的事情。我们的团队在不确定性中以纪律、韧性和信念坚持下去，得到了始终支持我们的股东的支持。我们在被摘牌不到一年后重新回到了纳斯达克。</p>
</div><p>“QT Imaging exists for a simple and deeply personal reason. Women deserve better options for breast imaging, earlier answers, and care that puts their safety and dignity first. Everything we have done has been in service of bringing this technology out of the lab and into the hands of clinicians and the women they serve. As a stronger company with a clear mission, we believe a Nasdaq listing increases our visibility, expands our stockholder base, and supports long term value creation. We are proud of how far we have come and energized by what lies ahead.”</p>
<div class="lb-trans"><p>QT Imaging 的存在是出于一个简单而深刻的个人原因。女性应当拥有更好的乳腺成像选择、更早的答案，以及将她们的安全和尊严放在首位的护理。我们所做的一切都是为了将这项技术从实验室带到临床医生和她们所服务的女性手中。作为一家使命明确的更强大公司，我们相信纳斯达克上市将提高我们的知名度，扩大我们的股东基础，并支持长期价值创造。我们为自己走过的路感到自豪，并对未来充满活力。</p>
</div><p>QT Imaging met all Nasdaq Capital Market listing requirements, including financial, corporate governance, and regulatory criteria. The uplisting aligns with the Company’s long-term strategic vision of expanding its global footprint and advancing the Company into the future of technological advances.</p>
<div class="lb-trans"><p>QT Imaging 满足了所有纳斯达克资本市场的上市要求，包括财务、公司治理和监管标准。此次提升与公司的长期战略愿景相一致，即扩大其全球足迹并推动公司迈向技术进步的未来。</p>
</div><p>QT Imaging remains committed to delivering sustained value to its shareholders through innovation, operational excellence, and disciplined growth. Investors can look forward to further updates as the Company embarks on this exciting new chapter.</p>
<div class="lb-trans"><p>QT Imaging 仍然致力于通过创新、卓越运营和有序增长为股东提供持续价值。投资者可以期待在公司开启这一激动人心的新篇章时获得进一步的更新。</p>
</div><p><strong>About QT Imaging Holdings, Inc.</strong></p>
<div class="lb-trans"><p><strong>关于 QT Imaging Holdings, Inc.</strong></p>
</div><p>QT Imaging Holdings, Inc. is a public medical device company engaged in research, development, and commercialization of innovative body imaging systems using low frequency sound waves. QT Imaging Holdings, Inc. strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on the patient’s experience. For more information on QT Imaging Holdings, Inc., please visit the Company’s website at www.qtimaging.com.</p>
<div class="lb-trans"><p>QT Imaging Holdings, Inc.是一家公开的医疗设备公司，专注于使用低频声波进行创新体成像系统的研究、开发和商业化。QT Imaging Holdings, Inc.努力改善全球健康结果。其战略基于医疗成像对疾病的检测、诊断和治疗至关重要，并且应该是安全、可负担、可获得，并以患者体验为中心。有关 QT Imaging Holdings, Inc.的更多信息，请访问公司网站 www.qtimaging.com。</p>
</div><p>Breast Acoustic CT™ is a trademark of an affiliate of QT Imaging Holdings, Inc.</p>
<div class="lb-trans"><p>Breast Acoustic CT™是 QT Imaging Holdings, Inc.的一个关联公司的商标。</p>
</div><p><strong>Forward-Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明</strong></p>
</div><p>This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements contain words such as “will,” and “expect,” or the negative thereof or comparable terminology, and include (without limitation) statements regarding the uplisting to the Nasdaq Capital Market, plans for QT Imaging, new product development and introduction, and product sales growth and projected revenues. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. These risks include, but are not limited to: the Company’s ability to uplist to the Nasdaq Capital Market, including meeting the initial and continuous listing requirements; research results from the use of the QTI Breast Acoustic CT scanner, clinical studies, the ability of QT Imaging to sell and deploy the QTI Breast Acoustic CT scanner, the ability to extend product offerings into new areas or products, the ability to commercialize technology, unexpected occurrences that deter the full documentation and “bring to market” plan for products, trends and fluctuations in the industry, changes in demand and purchasing volume of customers, unpredictability of suppliers, the ability to attract and retain qualified personnel and the ability to move product sales to production levels. Additional factors that could cause actual results to differ are discussed under the heading “Risk Factors” and in other sections of QT Imaging Holding’s filings with the SEC, and in its other current and periodic reports filed or furnished from time to time with the SEC. All forward-looking statements in this press release are made as of the date hereof, based on information available to QT Imaging Holdings as of the date hereof, and QT Imaging Holdings assumes no obligation to update any forward-looking statement.</p>
<div class="lb-trans"><p>本新闻稿包含根据 1933 年证券法第 27A 条及 1934 年证券交易法第 21E 条的修订版的前瞻性声明。这些声明包含 “将” 和 “预计” 等词语，或其否定形式或类似术语，包括（但不限于）关于提升至纳斯达克资本市场的声明、QT Imaging 的计划、新产品开发和推出、产品销售增长和预计收入的声明。前瞻性声明涉及某些风险和不确定性，实际结果可能与任何此类声明中讨论的结果有重大差异。这些风险包括但不限于：公司提升至纳斯达克资本市场的能力，包括满足初始和持续上市要求；使用 QTI Breast Acoustic CT 扫描仪的研究结果、临床研究、QT Imaging 销售和部署 QTI Breast Acoustic CT 扫描仪的能力、将产品扩展到新领域或产品的能力、商业化技术的能力、阻碍产品全面文档和 “推向市场” 计划的意外事件、行业趋势和波动、客户需求和采购量的变化、供应商的不可预测性、吸引和留住合格人员的能力以及将产品销售提升至生产水平的能力。可能导致实际结果有所不同的其他因素在 QT Imaging Holdings 向 SEC 提交的文件以及其不时提交或提供的其他当前和定期报告的 “风险因素” 标题下和其他部分中进行了讨论。本新闻稿中的所有前瞻性声明均基于 QT Imaging Holdings 截至本日期的信息，QT Imaging Holdings 不承担更新任何前瞻性声明的义务。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjAxMjc1NDk4ODZyMQ" alt="" original-src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260127549886r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en"/></p>
<p>View source version on businesswire.com: https://www.businesswire.com/news/home/20260127549886/en/</p>
<div class="lb-trans"><p>查看商业资讯上的源版本：https://www.businesswire.com/news/home/20260127549886/en/</p>
</div><p><strong>For media inquiries, please contact:</strong></p>
<div class="lb-trans"><p><strong>媒体咨询，请联系：</strong></p>
</div><p><strong>Stephen Kilmer</strong></p>
<div class="lb-trans"><p><strong>Stephen Kilmer</strong></p>
</div><p>Head of Investor Relations</p>
<div class="lb-trans"><p>投资者关系负责人</p>
</div><p>Stephen.Kilmer@qtimaging.com</p>
<div class="lb-trans"><p>Stephen.Kilmer@qtimaging.com</p>
</div><p>Direct: (646) 274-3580</p>
<div class="lb-trans"><p>电话： (646) 274-3580</p>
</div><p>Source: QT Imaging Holdings, Inc.</p>
<div class="lb-trans"><p>来源：QT Imaging Holdings, Inc.</p>
</div>

QT Imaging 宣布在纳斯达克市场升级上市 | QTIH 股票新闻